secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2022-03-10T23:59:59+00:00
Accession:  0001104659-22-032444
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ekso Bionics CCO William Shaw resigns; remains as consultant through June 2022
------------------------------------------------------------------------------

- CCO William Shaw resigns effective March 11, 2022, to join another company.
- Will serve as independent contractor through June 30, 2022, assisting with transition and special projects.
- Entitled to $225/hour or $1,800/day compensation plus Q1 2022 bonus and continued equity vesting.
- Eligible for up to $2,500 per candidate sourced (max two) if hired by company.
- Transition agreement includes standard release of claims and non-disparagement clause.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000110465922032444/0001104659-22-032444-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000110465922032444/tm228907d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-032444

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer